End-of-day quote
Shenzhen S.E.
03:30:00 20/05/2024 am IST
|
5-day change
|
1st Jan Change
|
9.42
CNY
|
+1.62%
|
|
+4.20%
|
-33.05%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
4,683
|
6,155
|
11,206
|
7,598
|
6,378
|
4,270
|
-
|
Enterprise Value (EV)
1 |
4,683
|
6,155
|
11,206
|
7,598
|
6,378
|
4,270
|
4,270
|
P/E ratio
|
-
|
33.8
x
|
53.2
x
|
42.6
x
|
117
x
|
16
x
|
9.92
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.27
x
|
4
x
|
-
|
4.05
x
|
3.24
x
|
1.67
x
|
1.16
x
|
EV / Revenue
|
3.27
x
|
4
x
|
-
|
4.05
x
|
3.24
x
|
1.67
x
|
1.16
x
|
EV / EBITDA
|
-
|
-
|
-
|
18.9
x
|
22.1
x
|
5.66
x
|
4.32
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
4.9
x
|
-
|
3.52
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
4,18,751
|
4,24,243
|
4,25,433
|
4,53,619
|
4,53,301
|
4,53,301
|
-
|
Reference price
2 |
11.18
|
14.51
|
26.34
|
16.75
|
14.07
|
9.420
|
9.420
|
Announcement Date
|
09/04/20
|
16/04/21
|
11/04/22
|
25/04/23
|
18/04/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,433
|
1,539
|
-
|
1,877
|
1,969
|
2,552
|
3,691
|
EBITDA
1 |
-
|
-
|
-
|
402.1
|
288
|
755
|
988
|
EBIT
1 |
-
|
238.3
|
-
|
183.4
|
44.97
|
289
|
466
|
Operating Margin
|
-
|
15.48%
|
-
|
9.77%
|
2.28%
|
11.32%
|
12.63%
|
Earnings before Tax (EBT)
1 |
-
|
206.8
|
-
|
181.4
|
37.08
|
287
|
464
|
Net income
1 |
-
|
181.6
|
209.9
|
168
|
56.07
|
266
|
430
|
Net margin
|
-
|
11.8%
|
-
|
8.95%
|
2.85%
|
10.42%
|
11.65%
|
EPS
2 |
-
|
0.4297
|
0.4955
|
0.3929
|
0.1200
|
0.5900
|
0.9500
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
09/04/20
|
16/04/21
|
11/04/22
|
25/04/23
|
18/04/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
15.5%
|
-
|
10.7%
|
2.58%
|
10.6%
|
14.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
2.98%
|
-
|
3.6%
|
5.1%
|
Assets
1 |
-
|
-
|
-
|
5,632
|
-
|
7,389
|
8,431
|
Book Value Per Share
|
-
|
2.960
|
-
|
4.750
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
0.4500
|
-
|
-0.0100
|
-
|
-
|
-
|
Capex
1 |
-
|
699
|
-
|
1,396
|
642
|
562
|
99
|
Capex / Sales
|
-
|
45.38%
|
-
|
74.36%
|
32.62%
|
22.02%
|
2.68%
|
Announcement Date
|
09/04/20
|
16/04/21
|
11/04/22
|
25/04/23
|
18/04/24
|
-
|
-
|
Last Close Price
9.42
CNY Average target price
20
CNY Spread / Average Target +112.31% Consensus |
1st Jan change
|
Capi.
|
---|
| -33.05% | 582M | | +5.31% | 106B | | -6.47% | 63.94B | | +72.86% | 49.34B | | +16.94% | 39.15B | | +5.28% | 32.86B | | +14.48% | 20.29B | | +15.10% | 17.21B | | +18.07% | 15.28B | | +4.83% | 14.58B |
Other Commodity Chemicals
|